Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-13

Clinical Trial Update: Hormone Therapy Effects on CVD Risk Factors

View source ↗

Summary

A completed clinical trial update examines the effects of hormone therapy on cardiovascular disease risk factors, relevant to postmenopausal individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Conjugated Estrogens (ESTROGENS, CONJUGATED)
  • ESTRADIOL (Estradiol)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Status: COMPLETED